Inflammatory demyelinating CNS disorder in a case of X-linked Charcot-Marie-Tooth disease: positive response to natalizumab

J Neurol. 2012 Sep;259(9):1967-9. doi: 10.1007/s00415-012-6467-9. Epub 2012 Mar 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Charcot-Marie-Tooth Disease / drug therapy*
  • Charcot-Marie-Tooth Disease / genetics
  • Connexins / genetics
  • Gap Junction beta-1 Protein
  • Humans
  • Immunologic Factors / therapeutic use*
  • Magnetic Resonance Imaging
  • Male
  • Mutation / genetics
  • Natalizumab
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Connexins
  • Immunologic Factors
  • Natalizumab